Featured
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Dyadic, Sanofi in Research Collaboration
To explore the potential of its C1 technology to produce multiple types of biologic vaccines and drugs of interest09.18.18
-
Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
AstraZeneca Joins Horizon's Genomics Discovery Initiative
Horizon Discovery's Edit-R crRNA libraries adopted by AstraZeneca as part of its functional genomics discovery platform09.18.18
-
APIs | Breaking News | Facilities | Industry News
Lonza Launches Early-Intermediates Supply Initiative for Small-Molecule APIs
Addresses concerns regarding over-dependence on regional supply of pharma ingredients to the Western Pharma industry09.18.18
-
Breaking News | Capsules | Collaborations & Alliances | Packaging & Tracking
PCI, CSP Technologies in Exclusive Activ-Blister Alliance
To provide clinical trials and stability testing utilizing Activ-Blister packaging solutions09.17.18
-
Industry News
Regeneron to Invest $800M in Rensselaer
To expand its lab space, manufacturing capacity and warehouse facilities; will create 1,500 new jobs09.14.18
-
Bio News | Breaking News | Drug Development | Industry News
Allergan to Acquire Bonti for $195M
Adds new neurotoxin programs to medical aesthetics pipeline09.14.18
-
APIs | Breaking News | Facilities | Industry News | Inspections
Asymchem Passes FDA Inspection at API Mfg. Site
Reports successful FDA inspection of Tianjin 2 development and commercial manufacturing facility with no Form 483 issued09.14.18
-
Aseptic Processing | Bio News | Breaking News | Facilities | Industry News
IPS to Provide Engineering Solutions for Althea's New Mfg. Facility
Althea recently expanded operations to include manufacturing of highly potent drug products as well as ADCs09.14.18
-
Industry News
Sanofi Restructures Two Global Business Units
To focus on operations in mature markets and across emerging markets09.13.18
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Industry News
Pall, Aetos Partner to Deliver Biosimilar Mfg. Solutions
Will combine bioprocessing equipment with high-quality/high-titer cell lines and scalable manufacturing processes09.13.18
-
Bio News | Collaborations & Alliances | Industry News
Cambrex Completes Halo Acquisition
Initially announced in July 2018, the deal closed for approximately $425 million09.12.18
-
APIs | Cytotoxics and High Potency Manufacturing
HPAPI Technology Evolution
Handling of high potency compounds for API and DP from development on a laboratory scale and scale-up to commercial.Martina Kotthaus, Jeff Dinyer, Anil Kane and Marvin Faber, Patheon, part of Thermo Fisher Scientific 09.11.18
-
Clinical Trial Materials | Supply Chain
Supply Chain Olympics
Clinical trial supply chain management: Changing without delayAdam Runsdorf, President WDPrx - Woodfield Pharmaceutical, LLC 09.11.18
-
Biosimilars
Biosimilar Market Trends
2017 was a record year for biosimilar approvals.Fiona Greer and Bruno Speder, SGS 09.11.18
-
Biologics, Proteins, Vaccines | Injectables
Next-Gen Biologics Packaging & Delivery
As the frontier of drug innovation evolves, so must the design of packaging and delivery systems.09.11.18
- Tropichem Invests in Spot-On Manufacturing
- Propanc, University of Jaén, Spain Enter Collaboration
- Astellas Announces Key Promotion
- Molecular Templates, Takeda Enter Agreement
- APEIRON & LDC Enter Partnership
- Evonik Completes €36M Expansion
- Zosano Pharma Completes Registration Batches of M207
- Dyadic, Sanofi in Research Collaboration
- Neurimmune Achieves Milestone in Ono Collaboration
- AstraZeneca Joins Horizon's Genomics Discovery Initiative
Contract Service Directory
Search the Directories for A Company:
